Gaipa et al
1 reported immunophenotypic modulation in a series of children with precursor-B-ALL, treated according to the AIEOP-BFM ALL 2000 protocol. In a comment on this paper we reported the same observation in children treated according to the DCOG ALL-9 protocol. 2 In addition, we exposed blast cells of five different patients, obtained at diagnosis, during 96 h to four different cytotoxic drugs (MTT test) and observed a comparable immunophenotypic modulation as observed ex vivo in patients undergoing treatment. Furthermore, we observed a clear relation between cell death and modulation and therefore concluded that antigen modulation can be mimicked in vitro and might, at least in part, be caused by drug-induced cell death. In a reply to our paper, Gaipa et al 2 do not fully agree with our conclusions.
Firstly, they mention that in the MTT culture system blast cells might not survive for 96 h without the support of a bone marrowderived stroma layer and that spontaneous apoptosis may occur. We agree with Gaipa et al that the MTT test is not optimal for culturing ALL cells and that spontaneous apoptosis may occur. In fact, the mean viability of control cells (not exposed to drugs) after 96 h culture in the reported experiments was 69% (range 40-95%). These control cells also showed the characteristic immunophenotypic modulation, suggesting that the modulation process is related to general cell death, independent of the type of apoptotic signal.
Secondly, Gaipa et al 3 indicate that gating based on FSC/SSC patterns excluded the dead and dying cells from the viable cell population and that modulated leukemic cells in their experiments were always located within the same scatter area as at diagnosis. We agree that it is possible to use this gating strategy to discriminate viable and dead cells when samples are treated with NH 4 Cl (or comparable lysing solutions) to lyse red blood cells. However, in our experience this is not possible when some commercially available lysing solutions (eg, BD FACSLysing) are used. When using BD FACSLysing solution, only part of the modulated cell population was located outside the characteristic scatter location for viable cells, whereas the majority of the modulated cells could not easily be separated from the viable cells based on light scatter characteristics. When the dead or dying cell population is relatively small, as in follow-up samples, this is even harder. Thus, the preciseness of the gating procedure based on light scatter characteristics is dependent on the type of lysing solution used.
Comparable to the results shown in the reply by Gaipa et al, back-gating of modulated cells present in follow-up samples from precursor-B-ALL patients treated within the DCOG-ALL-9 protocol showed that the vast majority of cells had the light scatter characteristics similar to those of leukemic cells at diagnosis. The difference in light scatter characteristics between in vivo modulated cells and in vitro modulated cells is not yet clear, but may be related to different stages of apoptosis, as recently reported by Diaz et al. 4 The relatively long exposure of the leukemic cells in the MTT assay (96 h) may result in late stages of apoptosis (with associated changes in light scatter characteristics), whereas in vivo such late apoptotic cells are already removed from the circulation and in all remaining circulating leukemic cells apoptosis may have been triggered just recently. Time course studies, preferably using bone marrow stroma-supported culture system, are required to further test this assumption.
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